Where Tech Meets Bio
Latest News
Tokyo-based Elix (founded 2016) has launched Elix Discovery, an AI drug discovery platform powered by federated learning models trained on proprietary compound data from 16 …
Read More
Google Expands MedGemma Collection With Multimodal Health AI Models for Open Development
Google Research has released two new models—MedGemma 27B Multimodal and MedSigLIP—as part of its open-source Health AI Developer Foundations (HAI-DEF) initiative, expanding the MedGemma suite …
Read More
Xaira Therapeutics Appoints Biotech Exec Behind Belharra and Ambys as President and COO to Scale AI-Driven Drug Discovery Platform
Xaira Therapeutics, the AI-native biotech launched in 2024 with over $1 billion in funding, has appointed biotech executive Jeff Jonker as President and Chief Operating …
Read More
Latest News
NIH To End Funding for Animal-Only Studies, Backing Shift to New Approach Methodologies
datma Launches Free Tool for Pharma to Assess Biomarker Coverage in Federated RWD
AbbVie Acquires Capstan Therapeutics for $2.1B, Gaining In Vivo CAR-T Platform Targeting Autoimmune Diseases
Chai Discovery Releases All-Atom Foundation Model for Zero-Shot Antibody Design with 16–20% Hit Rates
Arc Institute Opens Virtual Cell Challenge With $175K in AI Benchmarking Prizes
SandboxAQ Releases Public Database Containing 5.2 Million Synthetic Protein-Ligand Structures
Latest Insights
by Andreas Dreps, Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
The field of oncology is experiencing a proliferation of cancer therapies. In 2024 alone, the U.S. Food and Drug Administration (FDA) issued more than 60 …
Read More
by Dominik Tomicevic
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
An estimated 6.9 million Americans aged 65 and older are living with Alzheimer’s. Without major medical breakthroughs, that number is projected to rise to 13.8 …
Read More
Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome
by Louise von Stechow
AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis
by Adele Ruder, Alexander Hustinx, Louise von Stechow
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
by Dominik Tomicevic
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
by BiopharmaTrend
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
by BiopharmaTrend
AI in Drug Safety: From Concept to Reality, The Industry's Path Forward
by Dr. Karthik Muthusamy
Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development
by Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
by Andreas Dreps, Bea Mann, PhD
From Our Partners
Sponsored by
RECEPTOR.AI
This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery
Sponsored by
OPTIC
AI Is Key to Democratizing Drug Discovery
Sponsored by
Trialize
Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials
Sponsored by
Lantern Pharma
How AI Empowers Biomarker-Driven Clinical Trials
Partner Events

RNA Leaders USA Congress
Event Date: Sept. 10, 2025 - Sept. 11, 2025
Location: United States of America (Boston Exhibition & Convention Center)
Website: Link
Promo Code: MMBioPharmaTrend15
Read more ›››

Interactive Response Technologies 2025
Event Date: Oct. 14, 2025 - Oct. 15, 2025
Location: United States of America (The Westin Copley Place, Boston, MA)
Website: Link
Promo Code: IRT25BPT
Read more ›››

The 12th Aging Research & Drug Discovery Meeting
Event Date: Aug. 25, 2025 - Aug. 29, 2025
Location: Denmark (Ceremonial Hall, University of Copenhagen)
Website: Link
Case Studies
Sponsored by
RECEPTOR.AI
ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest
Sponsored by
Roivant Sciences
QUAISAR Computational Platform for Designing Targeted Protein Degraders
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Sponsored by
Arctoris
Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery
Sponsored by
Celeris Therapeutics
Application of AI-driven Xanthos Platform for Designing Protein Degraders
Sponsored by
Trialize
Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days
Sponsored by
Biocompare
Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness
Sponsored by
Science Exchange
How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange
Interviews
Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey
Dr. James Field on Breaking the 'Cognition Barrier' in Antibody Discovery with AI and Robotics
Navigating Next Wave of Protein Design with Elise de Reus from Cradle
Targeted Protein Degradation: a New Approach to Small Molecule Therapeutics
Most Read
21 Life Science Marketplaces to Try in 2024
11 Notable Companies Enabling Decentralized Clinical Trials
The CRO Industry in Flux: Navigating Technology, Business Models, and Trends in Pharma R&D Outsourcing
17 Companies Building the Future of Drug Development on a Chip